Adaptimmune Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Share-based compensation - Option Plans (Details)

Share-based compensation - Option Plans (Details)					1 Months Ended		6 Months Ended	12 Months Ended				48 Months Ended
Share-based compensation - Option Plans (Details)	Nov. 28, 2016	Aug. 11, 2016	Jun. 23, 2016	Mar. 16, 2015 GBP (£) item	Aug. 31, 2016 director shares	Dec. 31, 2014	Dec. 31, 2015 shares	Dec. 31, 2016 shares	Jun. 30, 2015 shares	Jun. 30, 2014 shares	Dec. 31, 2009	Dec. 31, 2014
Share based compensation
Maximum value of option grants per participant \| £				£ 30,000
Option Exercised (in shares)							0	63,192	0	2,265,000
Scheme limit, grants as a percentage of fully diluted share capital of the Company immediately following the IPO (as a percent)				8.00%
Scheme limit, automatic increase percentage (as a percent)				4.00%
Number of option schemes \| item				3
Accelerated vesting (in shares)					361,222
Number of non-executive directors \| director					2
Options granted in March 2015 and on May 11,2015
Share based compensation
Contractual term (in years)				10 years
Options granted in March 2015 and on May 11,2015 \| First anniversary
Share based compensation
Vesting percentage (as a percent)				25.00%
Options granted in March 2015 and on May 11,2015 \| Monthly installments over the following three years
Share based compensation
Vesting percentage (as a percent)				75.00%
Vesting period (in years)				3 years
Options granted in 2009
Share based compensation
Vesting percentage (as a percent)											100.00%
Vesting period (in years)											3 years
Contractual term (in years)											10 years
Options granted in 2011, 2012, 2013, and April 2014
Share based compensation
Contractual term (in years)												10 years
Options granted in 2011, 2012, 2013, and April 2014 \| First anniversary
Share based compensation
Vesting percentage (as a percent)												25.00%
Vesting period (in years)												1 year
Options granted in 2011, 2012, 2013, and April 2014 \| Annual installments over the following three years
Share based compensation
Vesting percentage (as a percent)												75.00%
Vesting period (in years)												3 years
Options granted in December 2014
Share based compensation
Contractual term (in years)						10 years
Options granted in December 2014 \| First anniversary
Share based compensation
Vesting percentage (as a percent)						25.00%
Vesting period (in years)						1 year
Options granted in December 2014 \| Monthly installments over the following three years
Share based compensation
Vesting percentage (as a percent)						75.00%
Vesting period (in years)						3 years
Non-executive director \| Options granted on June 23, 2016 \| First anniversary
Share based compensation
Vesting percentage (as a percent)			25.00%
Vesting period (in years)			1 year
Non-executive director \| Options granted on June 23, 2016 \| Monthly installments over the following two years
Share based compensation
Vesting percentage (as a percent)			75.00%
Vesting period (in years)			2 years
Non-executive director \| Options granted on August 11, 2016 \| First anniversary
Share based compensation
Vesting percentage (as a percent)		100.00%
Vesting period (in years)		1 year
Non-executive director \| Options granted on November 28, 2016 \| First anniversary
Share based compensation
Vesting percentage (as a percent)	25.00%
Vesting period (in years)	1 year
Non-executive director \| Options granted on November 28, 2016 \| Monthly installments over the following two years
Share based compensation
Vesting percentage (as a percent)	75.00%
Vesting period (in years)	2 years